Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.99 USD
−4.30 M USD
64.99 M USD
3.03 M
About Sanara MedTech Inc.
Sector
Industry
CEO
Ron T. Nixon
Website
Headquarters
Fort Worth
Founded
1982
FIGI
BBG000KLGDZ6
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SMTI is 34.94 USD — it has increased by 2.43% in the past 24 hours. Watch Sanara MedTech Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sanara MedTech Inc. stocks are traded under the ticker SMTI.
SMTI stock has risen by 3.28% compared to the previous week, the month change is a −8.08% fall, over the last year Sanara MedTech Inc. has showed a −10.41% decrease.
We've gathered analysts' opinions on Sanara MedTech Inc. future price: according to them, SMTI price has a max estimate of 50.00 USD and a min estimate of 44.00 USD. Watch SMTI chart and read a more detailed Sanara MedTech Inc. stock forecast: see what analysts think of Sanara MedTech Inc. and suggest that you do with its stocks.
SMTI reached its all-time high on Jun 13, 2008 with the price of 500.00 USD, and its all-time low was 0.50 USD and was reached on Jun 11, 2002. View more price dynamics on SMTI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SMTI stock is 2.65% volatile and has beta coefficient of 1.12. Track Sanara MedTech Inc. stock price on the chart and check out the list of the most volatile stocks — is Sanara MedTech Inc. there?
Today Sanara MedTech Inc. has the market capitalization of 305.42 M, it has increased by 0.35% over the last week.
Yes, you can track Sanara MedTech Inc. financials in yearly and quarterly reports right on TradingView.
Sanara MedTech Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SMTI earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.62 USD resulting in a 45.16% surprise. The estimated earnings for the next quarter are −0.34 USD per share. See more details about Sanara MedTech Inc. earnings.
Sanara MedTech Inc. revenue for the last quarter amounts to 21.67 M USD, despite the estimated figure of 20.70 M USD. In the next quarter, revenue is expected to reach 22.75 M USD.
SMTI net income for the last quarter is −2.86 M USD, while the quarter before that showed −3.50 M USD of net income which accounts for 18.44% change. Track more Sanara MedTech Inc. financial stats to get the full picture.
No, SMTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 107.00 employees. See our rating of the largest employees — is Sanara MedTech Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanara MedTech Inc. EBITDA is −4.04 M USD, and current EBITDA margin is −6.14%. See more stats in Sanara MedTech Inc. financial statements.
Like other stocks, SMTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanara MedTech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanara MedTech Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanara MedTech Inc. stock shows the buy signal. See more of Sanara MedTech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.